↓ Skip to main content

Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study

Overview of attention for article published in Frontiers in oncology, March 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley